UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 5, 2003
INVIVO CORPORATION
Delaware
000-15963 | 77-0115161 | |
|
||
(Commission File Number) |
(IRS Employer Identification No.) |
4900 Hopyard Road, Suite 210, Pleasanton, CA | 94588 | |
|
||
(Address of principal executive offices) | (Zip code) |
(925) 468-7600
Item 7. Financial Statements and Exhibits. | ||||||||
Item 12. Results of Operations and Financial Condition. | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
Exhibit 99.1 |
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
The following exhibit is filed herewith:
Exhibit No. | Exhibit Title | |
99.01 | Press Release, dated August 5, 2003, issued by Invivo Corporation. |
Item 12. Results of Operations and Financial Condition.
The information in this report and the exhibits attached hereto are being furnished pursuant to Item 12 of Form 8-K and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Exchange Act of 1934 or the Securities Act of 1933, whether made before or after the date hereof and irrespective of any general incorporation language in any filings. On August 5, 2003, Invivo Corporation issued a press release announcing its results for the fourth quarter and fiscal year ended June 30, 2003. A copy of the press release is attached as Exhibit 99.01 to this Current Report.
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 5, 2003 | INVIVO CORPORATION | |||
By: | /s/ JOHN F. GLENN
John F. Glenn Vice President-Finance and Chief Financial Officer |
-3-
EXHIBIT INDEX
Exhibit No. | Description of Exhibit | |
99.01 | Press Release, dated August 5, 2003, issued by Invivo Corporation. |
-4-